Significant inhibition of HCC proliferation and metastasis can be achieved through either butyrate supplementation or the depletion of SCAD gene (ACADS), which encodes a key enzyme for butyrate metabolism (42). The gene discussed is ACADS; the disease is hepatocellular carcinoma.